Search Results

There are 65609 results for: content related to: Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon- α therapy: possible etiology of HCV-associated immune thrombocytopenia

  1. Abstract of Papers Submitted to the American Association of the Study of Liver Disease

    Hepatology

    Volume 22, Issue S4, October 1995, Pages: S107–S514,

    Article first published online : 5 DEC 2005, DOI: 10.1002/hep.1840220703

  2. Abstracts of papers submitted to the american association for the study of liver diseases

    Hepatology

    Volume 18, Issue S7, October 1993, Pages: 57A–346A,

    Article first published online : 12 DEC 2005, DOI: 10.1002/hep.1840180703

  3. Abstracts of the international association for the study of the liver biennial Scientific meeting

    Hepatology

    Volume 19, Issue 4, April 1994, Pages: I1–I144,

    Article first published online : 5 DEC 2005, DOI: 10.1002/hep.1840190444

  4. Abstracts

    Hepatology

    Volume 14, Issue S4, October 1991, Pages: S48–S290,

    Article first published online : 8 DEC 2005, DOI: 10.1002/hep.1840140713

  5. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  6. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Article first published online : 24 SEP 2008, DOI: 10.1002/hep.22644

  7. Role of serum soluble Fas/soluble Fas ligand and TNF-α on response to interferon-α therapy in chronic hepatitis C

    Liver

    Volume 20, Issue 4, August 2000, Pages: 305–311, Mitsuo Toyoda, Satoru Kakizaki, Norio Horiguchi, Ken Sato, Hisashi Takayama, Hitoshi Takagi, Takeaki Nagamine and Masatomo Mori

    Article first published online : 24 DEC 2001, DOI: 10.1034/j.1600-0676.2000.020004305.x

  8. You have free access to this content
    AASLD Abstracts (pp. 383A–483A)

    Hepatology

    Volume 38, Issue S4, October 2003, Pages: 383A–483A,

    Article first published online : 10 FEB 2006, DOI: 10.1002/hep.1840380506

  9. Hepatitis C virus genotypes and hepatic fibrosis regulate 24-h decline of serum hepatitis C virus RNA during interferon therapy in patients with chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 18, Issue 4, April 2003, Pages: 404–410, YOSHIYASU KARINO, JOUJI TOYOTA, MASAAKI SUGAWARA, KAYO MIYAZAKI, YASUAKI KUWATA, KATSU YAMAZAKI, TAKAHIRO SATO, TAKUMI OHMURA and TAKASHI MATSUSHIMA

    Article first published online : 23 SEP 2008, DOI: 10.1046/j.1440-1746.2003.03009.x

  10. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Article first published online : 5 OCT 2005, DOI: 10.1002/hep.20927

  11. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level

    Journal of Medical Virology

    Volume 68, Issue 3, November 2002, Pages: 343–351, Shigenobu Kawai, Osamu Yokosuka, Fumio Imazeki, Hiromitsu Saisho and Chitose Mizuno

    Article first published online : 9 SEP 2002, DOI: 10.1002/jmv.10209

  12. Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)

    Hepatology Research

    Volume 40, Issue 4, April 2010, Pages: 347–368, Izumi Namiki, Shuhei Nishiguchi, Keisuke Hino, Fumitaka Suzuki, Hiromitsu Kumada, Yoshihito Itoh, Yusuhiro Asahina, Akihiro Tamori, Naoki Hiramatsu, Norio Hayashi and Masatoshi Kudo

    Article first published online : 29 MAR 2010, DOI: 10.1111/j.1872-034X.2010.00642.x

  13. You have free access to this content
    2011 Japanese Society for Dialysis Therapy Guidelines for the Treatment of Hepatitis C Virus Infection in Dialysis Patients

    Therapeutic Apheresis and Dialysis

    Volume 16, Issue 4, August 2012, Pages: 289–310, Takashi Akiba, Kazuhiko Hora, Michio Imawari, Chifumi Sato, Eiji Tanaka, Namiki Izumi, Takashi Harada, Ryoichi Ando, Kan Kikuchi, Tadashi Tomo, Hideki Hirakata and Tadao Akizawa

    Article first published online : 11 JUN 2012, DOI: 10.1111/j.1744-9987.2012.01078.x

  14. You have free access to this content
    AASLD Abstracts 1143–1352

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 817A–911A,

    Article first published online : 24 SEP 2008, DOI: 10.1002/hep.22645

  15. American association for the study of liver diseases

    Hepatology

    Volume 16, Issue S4, October 1992, Pages: 1A–292A,

    Article first published online : 5 DEC 2005, DOI: 10.1002/hep.1840160702

  16. You have free access to this content
    IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

    Clinical & Experimental Immunology

    Volume 126, Issue 1, October 2001, Pages: 92–100, M. Hirayama, T. Maruyama, H. Mitsui, H. Maekawa, H. Yamada, N. Hashimoto, K. Koike, S. Kimura, K. Yasuda, S. Iino and J. Green

    Article first published online : 7 JUL 2008, DOI: 10.1046/j.1365-2249.2001.01648.x

  17. Effect of Alcohol Intake on the Efficacy of Interferon Therapy in Patients with Chronic Hepatitis C as Evaluated by Multivariate Logistic Regression Analysis

    Alcoholism: Clinical and Experimental Research

    Volume 20, Issue s9, December 1996, Pages: 371A–377A, Satoshi Mochida, Kunihiko Ohnishi, Shuichi Matsuo, Kohji Kakihara and Kenji Fujiwara

    Article first published online : 11 APR 2006, DOI: 10.1111/j.1530-0277.1996.tb01811.x

  18. You have free access to this content
    Abstracts 432 to 661

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 431A–531A,

    Article first published online : 19 SEP 2007, DOI: 10.1002/hep.22018

  19. A prospective study of interferon therapy modified by pre-treatment viral load in cirrhotic patients

    Liver

    Volume 20, Issue 4, August 2000, Pages: 271–280, Yasushi Shiratori, Mistuhiko Moriyama, Fumio Imazeki, Hitoshi Ohkubo, Naohide Tanaka, Yasuyuki Arakawa, Haruhiko Yoshida, Osamu Yokosuka, Akitaka Shibuya, Kohei Matsuzaki, Etsuko Hashimoto, Naoaki Hayashi, Keiichi Hirata, Yasuo Ohashi, Masao Omata and (Tokyo-Chiba Hepatitis Research Group)

    Article first published online : 24 DEC 2001, DOI: 10.1034/j.1600-0676.2000.020004271.x

  20. Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-α therapy for patients with chronic hepatitis C

    Liver International

    Volume 25, Issue 2, April 2005, Pages: 247–253, Izumi Hasegawa, Etsuro Orito, Yasuhito Tanaka, Noboru Hirashima, Kenji Sakakibara, Mayumi Sakurai, Seiji Suzuki, Fuminaka Sugauchi, Tomoyoshi Ohno, Ryuzo Ueda and Masashi Mizokami

    Article first published online : 17 MAR 2005, DOI: 10.1111/j.1478-3231.2005.1096.x